0001214659-21-010561.txt : 20211018 0001214659-21-010561.hdr.sgml : 20211018 20211018170057 ACCESSION NUMBER: 0001214659-21-010561 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211015 FILED AS OF DATE: 20211018 DATE AS OF CHANGE: 20211018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McGrath Lynne Fahey CENTRAL INDEX KEY: 0001866270 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40483 FILM NUMBER: 211328782 MAIL ADDRESS: STREET 1: 28145 CEDAR POINT RD. CITY: EASTON STATE: MD ZIP: 21601 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alzamend Neuro, Inc. CENTRAL INDEX KEY: 0001677077 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811822909 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 3802 SPECTRUM BLVD, STREET 2: SUITE C112C CITY: TAMPA STATE: FL ZIP: 33612 BUSINESS PHONE: 844-722-6333 MAIL ADDRESS: STREET 1: 3802 SPECTRUM BLVD, STREET 2: SUITE C112C CITY: TAMPA STATE: FL ZIP: 33612 4 1 marketforms-54024.xml PRIMARY DOCUMENT X0306 4 2021-10-15 0001677077 Alzamend Neuro, Inc. ALZN 0001866270 McGrath Lynne Fahey 3802 SPECTRUM BOULEVARD, SUITE 112C TAMPA FL 33612 true false false false Common Stock 2021-10-15 4 M false 47222 0 A 50000 D Restricted Stock Grant 2021-10-15 4 M false 47222 0 D 2022-03-15 Common Stock 47222 50000 D Represents the vesting of restricted stock. Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc. The restricted stock grant was amended on October 13, 2021, such that 47,222 shares of restricted stock vested on October 15, 2021, and the remaining 50,000 shares of restricted stock shall vest on March 15, 2022. 2,778 shares previously vested on September 13, 2021. /s/ Lynne F. McGrath 2021-10-18